Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma'. Together they form a unique fingerprint.